Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Vasculitis
- Focus Therapeutic Use
- 26 Sep 2017 Status changed from not yet recruiting to recruiting.
- 06 Mar 2017 Planned End Date changed from 1 Mar 2018 to 1 Jun 2018.
- 06 Mar 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.